Good price  online

products details

Created with Pixso. Home Created with Pixso. Products Created with Pixso.
Chest Lung Cancer Drugs
Created with Pixso. Aprepitant Injectable Emulsion 130mg Vial 18ml Dosage for Chemotherapy Induced Nausea Vomiting Prevention NK1 Receptor Antagonist

Aprepitant Injectable Emulsion 130mg Vial 18ml Dosage for Chemotherapy Induced Nausea Vomiting Prevention NK1 Receptor Antagonist

Brand Name: Sichuan Kelun Pharmaceutical Co., Ltd.
Model Number: Aprepitant KL-20253052
MOQ: Negotiable
Price: Please contact a specialist WhatsApp:55342706
Delivery Time: Negotiable
Payment Terms: Western Union,MoneyGram,T/T
Detail Information
Place of Origin:
Chengdu, Sichuan, China
Certification:
NMPA/GMP
Active Ingredient:
Aprepitant
Specification:
18ml:130mg
Dosage:
130mg IV Infusion Over 30 Min
Storage Temperature:
Below 30C
Shelf Life:
24 Months
Approval Code:
H20253052
Packaging Details:
Negotiable
Supply Ability:
Negotiable
Highlight:

NK1 Receptor Antagonist CINV

,

Injectable Neurokinin 1 Blocker

,

Delayed Phase CINV Prevention

Product Description
Aprepitant 18ml:130mg
[Product Name]

Generic Name: Aprepitant

Specification: 18ml:130mg

[Active Ingredient]

Aprepitant

[Indications]

Prevention of acute and delayed CINV with highly and moderately emetogenic chemotherapy. Triple regimen with 5-HT3 antagonist and dexamethasone.

[Mechanism of Action]

Selective high-affinity NK1 receptor antagonist blocking substance P-mediated emetic reflex in the CNS. Superior delayed-phase CINV control.

[Dosage]

130mg IV infusion over 30 min on day 1, 30 min before chemotherapy. Use with dexamethasone and 5-HT3 antagonist.

[Adverse Reactions]

Fatigue, hiccups, constipation, headache, decreased appetite. CYP3A4 substrate; adjust concomitant CYP3A4 substrates.

[Storage]

Store below 30C. Keep out of reach of children.

[Shelf Life]

24 months

Approval: H20253052